logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
N

N. Thatcher

University of Pittsburgh

46H指数
258论文数
8.6K被引数
收录论文 29
发表时间
logo
Statistical controversies in clinical research: futility analyses in oncology-lessons on potential pitfalls from a randomized controlled trial
errANNALS OF ONCOLOGY
IF65.4
err2017-07-01
err11
errOAAI
errLesaffre, E.; Edelman, M. J.; Hanna, N. H.; Park, K.; Thatcher, N.; Willemsen, S.; Gaschler-Markefski, B.; Kaiser, R.; Manegold, C.
err分享
err收藏
Secondary efficacy results from a phase 3 study comparing efficacy and safety of biosimilar candidate ABP 215 with bevacizumab in patients with non-squamous non-small cell lung cancer (NSCLC)
errANNALS OF ONCOLOGY
IF65.4
err2016-10-01
err3
errOAAI
errThatcher, N.; Thomas, M.; Ostoros, G.; Pan, J.; Goldschmidt, J.; Hanes, V.
err分享
err收藏
Correlation of EGFR-expression with safety and efficacy outcomes in SQUIRE: a randomized, multicenter, open-label, phase III study of gemcitabine-cisplatin plus necitumumab versus gemcitabine-cisplatin alone in the first-line treatment of patients with stage IV squamous non-small-cell lung cancer
errANNALS OF ONCOLOGY
IF65.4
err2016-08-01
err65
errOAAI
errPaz-Ares, L.; Socinski, M. A.; Shahidi, J.; Hozak, R. R.; Soldatenkova, V.; Kurek, R.; Varella-Garcia, M.; Thatcher, N.; Hirsch, F. R.
err分享
err收藏
Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses
errANNALS OF ONCOLOGY
IF65.4
err2015-06-01
err74
errOAAI
errMitchell, P.; Thatcher, N.; Socinski, M. A.; Wasilewska-Tesluk, E.; Horwood, K.; Szczesna, A.; Martin, C.; Ragulin, Y.; Zukin, M.; Helwig, C.; Falk, M.; Butts, C.; Shepherd, F. A.
err分享
err收藏
Safety and Efficacy of Necitumumab (N) During Single-Agent Treatment to Progression Following Gemcitabine-Cisplatin (GC) Chemotherapy Plus Necitumumab (IMC-11F8/LY3012211) in the First-Line Treatment of Patients With Stage IV Squamous Non-Small Cell Lung Cancer (sq-NSCLC) (SQUIRE)
errINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
IF6.5
err2014-11-01
err0
errOAAI
errSocinski, M. A.; Thatcher, N.; Luft, A. V.; Szczesna, A.; Ciuleanu, T.; Szafranski, W.; Ramlau, R.; Balint, B.; Kazarnowicz, A.; Molinier, O.; Depenbrock, H.; Nanda, S.; Obasaju, C.; Paz-Ares, L.
err分享
err收藏
SQUIRE: A RANDOMIZED, MULTICENTER, OPEN-LABEL, PHASE III STUDY OF GEMCITABINE-CISPLATIN (GC) CHEMOTHERAPY PLUS NECITUMUMAB (IMC-11F8/LY3012211) VS GC ALONE IN THE FIRST-LINE TREATMENT OF PATIENTS (PTS) WITH STAGE IV SQUAMOUS NON-SMALL CELL LUNG CANCER (SQ-NSCLC): UPDATE ON KEY SUBGROUPS
errANNALS OF ONCOLOGY
IF65.4
err2014-09-01
err1
errOAAI
errSocinski, M. A.; Paz-Ares, L.; Luft, A. V.; Szczesna, A.; Ciuleanu, T. E.; Szafranski, W.; Reck, M.; Balint, B.; Park, K.; Schumann, C.; Hirsch, F. R.; Depenbrock, H.; Nanda, S.; Chouaki, N.; Thatcher, N.
err分享
err收藏
A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer
errANNALS OF ONCOLOGY
IF65.4
err2012-01-01
err120
errOAAI
errManegold, C.; van Zandwijk, N.; Szczesna, A.; Zatloukal, P.; Au, J. S. K.; Blasinska-Morawiec, M.; Serwatowski, P.; Krzakowski, M.; Jassem, J.; Tan, E. H.; Benner, R. J.; Ingrosso, A.; Meech, S. J.; Readett, D.; Thatcher, N.
err分享
err收藏
1st ESMO Consensus Conference in lung cancer; Lugano 2010: Small-cell lung cancer第一届ESMO肺癌共识会议; 卢加诺2010: 小细胞肺癌
errANNALS OF ONCOLOGY
IF65.4
err2011-09-01
err58
errOAAI
errStahel, R.; Thatcher, N.; Frueh, M.; Le Pechoux, C.; Postmus, P. E.; Sorensen, J. B.; Felip, E.
err分享
err收藏
The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trials
errANNALS OF ONCOLOGY
IF65.4
err2010-10-01
err92
errOAAI
errWheatley-Price, P.; Blackhall, F.; Lee, S-M; Ma, C.; Ashcroft, L.; Jitlal, M.; Qian, W.; Hackshaw, A.; Rudd, R.; Booton, R.; Danson, S.; Lorigan, P.; Thatcher, N.; Shepherd, F. A.
err分享
err收藏
The strength of female sex as a prognostic factor in small-cell lung cancer: a pooled analysis of chemotherapy trials from the Manchester Lung Group and Medical Research Council Clinical Trials Unit
errANNALS OF ONCOLOGY
IF65.4
err2010-02-01
err33
errOAAI
errWheatley-Price, P.; Ma, C.; Ashcroft, L. F.; Nankivell, M.; Stephens, R. J.; White, S. C.; Lorigan, P.; Thatcher, N.; Blackhall, F. H.; Shepherd, F. A.
err分享
err收藏
Sensitivity and specificity of immunohistochemical antibodies used to distinguish between benign and malignant pleural disease: a systematic review of published reports
errHISTOPATHOLOGY
IF4.1
err2006-11-27
err71
PREAI
errKing, J.; Thatcher, N.; Pickering, C.; Hasleton, P.
err分享
err收藏
A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group (BTOG1)
errANNALS OF ONCOLOGY
IF65.4
err2006-07-01
err58
errOAAI
errBooton, R.; Lorigan, P.; Anderson, H.; Baka, S.; Ashcroft, L.; Nicolson, M.; O'Brien, M.; Dunlop, D.; O'Byrne, K.; Laurence, V.; Snee, M.; Dark, G.; Thatcher, N.
err分享
err收藏
Sensitivity and specificity of immunohistochemical markers used in the diagnosis of epithelioid mesothelioma: a detailed systematic analysis using published data
errHISTOPATHOLOGY
IF4.1
err2006-01-19
err113
PREAI
errKing, JE; Thatcher, N; Pickering, CAC; Hasleton, PS
err分享
err收藏
Thoracic radiotherapy for limited-stage small-cell lung cancer: Controversies and future developments
errCLINICAL ONCOLOGY
IF3
err2005-12-01
err19
PREAI
errFaivre-Finn, C; Lee, LW; Lorigan, P; West, C; Thatcher, N
err分享
err收藏
Two randomised phase II trials of subcutaneous interleukin-2 and histamine dihydrochloride in patients with metastatic renal cell carcinoma
errBRITISH JOURNAL OF CANCER
IF6.8
err2005-08-30
err23
errOAAI
errDonskov, F; Middleton, M; Fode, K; Meldgaard, P; Mansoor, W; Lawrance, J; Thatcher, N; Nellemann, H; von der Maase, H
err分享
err收藏
A phase II trial with RFS2000 (rubitecan) in patients with advanced non-small cell lung cancer
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2005-07-01
err14
PREAI
errBaka, S; Ranson, M; Lorigan, P; Danson, S; Linton, K; Hoogendam, I; Mettinger, K; Thatcher, N
err分享
err收藏
Management of small-cell lung cancer
errANNALS OF ONCOLOGY
IF65.4
err2005-06-01
err32
errOAAI
errThatcher, N; Faivre-Finn, C; Lorigan, P
err分享
err收藏
Treatment of non-small-cell lung cancer: a perspective on the recent advances and the experience with gefitinib非小细胞肺癌的治疗: 吉非替尼的最新进展和经验
errBRITISH JOURNAL OF CANCER
IF6.8
err2004-08-31
err34
errOAAI
errOnn, A; Tsuboi, M; Thatcher, N
err分享
err收藏
Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel
errANNALS OF ONCOLOGY
IF65.4
err2004-03-01
err145
errOAAI
errGridelli, C; Ardizzoni, A; Le Chevalier, T; Manegold, C; Perrone, F; Thatcher, N; van Zandwijk, N; Di Maio, M; Martelli, O; De Marinis, F
err分享
err收藏
Identical chemotherapy schedules given on and off trial protocol in small cell lung cancer response and survival results在小细胞肺癌的反应和生存结果中，在试验方案内外给出相同的化疗方案
errBRITISH JOURNAL OF CANCER
IF6.8
err2002-08-27
err19
errOAAI
errBurgers, JA; Arance, A; Ashcroft, L; Hodgetts, J; Lomax, L; Thatcher, N
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
E
Enriqueta Felip
H 指数: 129 · 论文数: 1.5K
F
Frances A. Shepherd
H 指数: 127 · 论文数: 1.1K
L
Luis Paz‐Ares
H 指数: 116 · 论文数: 1.4K
M
Maria Zambon
H 指数: 104 · 论文数: 561
P
Pieter E. Postmus
H 指数: 94 · 论文数: 640
查看更多